✦ LIBER ✦

Phase III Study of Sunitinib Malate (SU11248) Versus Interferon-α as First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

✍ Scribed by Kesava Reddy; Ronald M. Bukowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Trial of Sunitinib Malate plus I

✍ Robert J. Motzer; Gary Hudes; George Wilding; Lawrence H. Schwartz; Subramanian 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

Phase II trial of continuous once-daily

✍ Carlos H. Barrios; David Hernandez-Barajas; Michael P. Brown; Se-Hoon Lee; Luis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 855 KB

PCN139 FINAL QUALITY OF LIFE (QOL) RESUL

✍ D Cella; MD Michaelson; AG Bushmakin; JC Cappelleri; C Charbonneau; ST Kim; JZ L 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Costs of managing adverse events in the

✍ Mickisch, G; Gore, M; Escudier, B; Procopio, G; Walzer, S; Nuijten, M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB

Regarding: ‘Costs of managing adverse ev

✍ Porta, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Reply: Costs of managing adverse events

✍ Mickisch, G H J; Escudier, B; Walzer, S; Nuijten, M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB